Charcot Marie Tooth Disease Clinical Trial
— DSI and HMSNOfficial title:
Disability Severity Scale (DSI) and Hereditary Motor and Sensory Neuropathy Overall Disability Scale (HMSN-R-ODS)
Verified date | February 2019 |
Source | University of Iowa |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The purpose of this research study is to create and validate two patient reported outcome (PRO) questionnaires. PRO questionnaires ask questions that help to measure disability in patients with inherited neuropathies. These questionnaires ask questions about what participants think disability is for themselves or others with inherited neuropathies. These questionnaires are a useful tool when evaluating whether treatments are working in the day to day life of an individual, although there are currently no questionnaires available specifically for people who have Charcot Marie Tooth disease (CMT).
Status | Completed |
Enrollment | 563 |
Est. completion date | February 2019 |
Est. primary completion date | February 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 10 Years and older |
Eligibility |
Inclusion Criteria: - individual has an inherited peripheral neuropathy or is suspected to have an inherited peripheral neuropathy - individual is 10-99 years of age - individual signs consent or assent form depending on age and requirements - individual is participating in INC 6601 at one of the participating sites OR is a participant on the INC Patient Registry Exclusion Criteria: - inability to provide informed consent - outside of age range - inability to complete questionnaire - does not understand English - is not participating in INC 6601 or on the INC Patient Registry |
Country | Name | City | State |
---|---|---|---|
United Kingdom | National Hospital of Neurology and Neurosurgery | London | |
United States | University of Iowa | Iowa City | Iowa |
United States | University of Rochester Medical Center | Rochester | New York |
Lead Sponsor | Collaborator |
---|---|
University of Iowa | Charcot-Marie-Tooth Association, Muscular Dystrophy Association, National Institute of Neurological Disorders and Stroke (NINDS), University of Rochester, University of South Florida |
United States, United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Disability Severity Index | The DSI asks the subject to provide information about how disability is reflected in general by equipment required for mobility. Therefore, the DSI asks the subject if a person in general was wearing AFOs (braces) for mobility, what level of disability would that reflect using both a quantitative measurement of score and a verbal method of scoring (none, mild, moderate, severe). These questions do not apply to the participant themselves, just in general how disabled they believe a person to be based on the mobility assistive devices that that person requires. Then a research team member will complete the last page which specifically asks about what that subject is using for mobility. | Approximately 30 minutes | |
Secondary | Hereditary Motor and Sensory Neuropathy Overall Disability Scale (HMSN-R-ODS) | The HMSN-R-ODS is a functional score about the subject asking about their daily activities and overall health. Questions are grouped in various sections and include: Changing and holding body positions; walking and movement; movement by transport; carrying, moving, or handling objects; self-care; household activities and duties; taking care (daily tasks) - general; meeting other people; work, study, and hobbies. These questions relate specifically to the subject and ask how they can perform these various activities with little to severe difficulty. | Approximately 30 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02561702 -
Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease
|
Phase 2 | |
Completed |
NCT00541164 -
Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease
|
Phase 1/Phase 2 | |
Recruiting |
NCT01918826 -
Evaluation of the Analgesic Efficiency of the Transcutaneous Neurostimulation in the Charcot Syndrome Marie Tooth on the Pains of Lower Limbs
|
N/A | |
Completed |
NCT01455623 -
Development and Validation of a Disability Severity Index for CMT
|
N/A | |
Recruiting |
NCT01203085 -
Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT
|
||
Recruiting |
NCT01193075 -
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
|